Trial intelligence / Profile preview

Estradiol add-on in Schizophrenia

NCT03848234Phase 3Completed

Sponsor
Tangent Data
Start
Dec 2015
Primary completion
Jul 2016
Modality
Hormone, Biologic
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of estradiol in schizophrenia, schizoaffective disorder and schizophreniform disorder, sponsored by Tangent Data. Started Dec 2015; status: completed.

02

Drugs

estradiol
03

Conditions

schizophreniaschizoaffective disorderschizophreniform disorder

Beyond the preview

Go deeper on NCT03848234.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03848234.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call